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1. Introduction
The research on organic micropollutants (OMPs) in wastewater 
has become a worldwide issue of increasing environmental concern, 
especially considering the growing interest in the reuse of treated 
wastewater. Thus, the application of post-treatment technologies 
such as biofiltration systems, UV irradiation or advanced oxidation 
processes is considered a promising solution to adequate the quality 
of secondary effluents in view of an eventual reclamation [1].
Despite the large number of studies investigating the fate and 
removal of various individual and specific groups of OMPs after 
post-treatments, so far little is known whether these processes 
affect the toxic activity of OMPs themselves and, consequently, 
of the effluents. This underdevelopment is mainly due to a lack 
of standardized protocols for the selection and the execution of 
biological assays, especially for specific modes of toxic action [2]. 
Another weakness is related to the use of techniques neither i) 
specific enough (in reaching the target endpoints) nor ii) adequately 
sensible. As the first issue is concerned, for instance Vibrio fischeri 
is frequently employed, but it is only able to detect the baseline 
toxicity [3]; for the second, the determination of estrogenic activity 
by means of traditional techniques (e.g. yeast estrogenic screen) 
does not allow a satisfactory degree of sensibility and robustness, 
while the application of human breast cancer MCF-7 cells for estro-
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ABSTRACT
The research on emerging pollutants in wastewater has become a worldwide issue of increasing environmental concern, especially considering 
the growing interest in wastewater reuse. However, the latter implies additional post-treatment after the conventional activated sludge processes, 
in order to produce a safer effluent. Our work aimed at determining the efficiency of reducing the toxicity associated with organic micropollutants 
(OMPs) in secondary wastewater effluents, using 3 different post-treatment technologies (granular activated carbon (GAC), sand biofiltration and 
UV irradiation): in particular, target chemical analysis of the OMPs most commonly founded in wastewater was coupled with effect-based assays 
(estrogenicity and mutagenicity). While chemical analysis assessed satisfactory performances for all 3 technologies in the abatement of selected 
OMPs, biological assays evidenced another perspective: both GAC and sand biofilters were significantly able to make the estrogenic load plummet; 
however, the UV system was ineffective in estrogenicity abatement, and its effluent exhibited also a slight mutagenicity, likely due to photo-transformation 
by-products. These results indicate that a synergistic combination of chemical analysis and biological assays can drive to a proper gauging of 
post-treatment technologies, taking into account not only the removal of OMPs, but also their overall toxicity.
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genicity detection ensures accurate and reproducible results thanks 
to its high concentration of estrogenic receptors.
Thus, the development of sensible and specific assays represents 
a valuable strength when profiling tertiary treatments [4, 5]. Indeed, 
effect-based monitoring approaches are required to gain information 
on the cumulative effects of complex mixtures characterizing waste-
water [6]: the detection of OMPs alone is not sufficient to evaluate 
the ecohazard of treated effluent and, ultimately, the negative effects 
on aquatic organisms [2, 7, 8].
The objective of this work was to determine the efficiency of 
three post-treatment technologies (granular activated carbon (GAC) 
biofiltration, sand biofiltration and UV irradiation) for the mitigation 
of estrogenic and mutagenic activities (measured by means of MCF-7 
cells and Ames test, respectively), therefore expanding the in-




Laboratory scale biofilters were used, consisting of two columns 
of methacrylate, each with 3 L of sand and granular activated 
carbon as filtering material, respectively. Both biofilters were fed 
with a secondary effluent (main characteristics: pH: 7.5, chemical 
oxygen demand (COD): 79 mg/L, ammonium (N-NH4): 0.9 mg/L 
and nitrate (N-NO3): 5.9 mg/L) that was spiked with selected OMPs 
(full details in Table S1 of Supplementary Materials). The detailed 
description of biofilters operation can be found in [9]: among a 
wider spectrum of operating conditions tested against OMPs re-
moval, the effect-based assays were carried out under an empty 
bed contact time (EBCT) of 4.8 h. During this period, two sampling 
campaigns were carried out for quantifying target OMPs and, on 
the second campaign, bioassays were executed on triplicate and 
duplicate for estrogenicity and mutagenicity, respectively.
2.1.2. UV system
The UV lab reactor was a 1 L cylindrical glass contactor provided 
with a low-pressure lamp (TNN 15/32, nominal power 15 W) emit-
ting monochromatic radiation at 254 nm. Similarly to biofilters, 
a secondary effluent (main characteristics: pH: 7.3, COD: 24 mg/L, 
N-NH4: 1.3 mg/L, NO3: 3.6 mg/L and turbidity: 4.7 NTU) spiked 
with selected OMPs was used (full details in Table S1 of 
Supplementary Materials). The detailed description of UV reactor 
operation can be found in [10]: again, among a wider spectrum 
of operating conditions where OMPs were detected, the effect-based 
assays were carried out under an UV dose of 1,200 mJ/cm2. For 
this experiment, OMPs were determined on duplicate whereas bio-
assays were executed on triplicate for estrogenicity and on duplicate 
for mutagenicity.
It is worth to note that, for both reactors, the treatment conditions 
we decided to test are stronger than those usually applied in 
full-scale systems: especially the UV dose, usually in the range 
of 50 – 200 mJ/cm2 [11]. However, these conditions were properly 
selected to ensure effectiveness towards not only the parent OMPs, 
but also their transformation products, which play a key role in 
the effect-based assays.
2.2. Organic Micropollutants
Several OMPs commonly found in secondary effluents were targeted 
in this work: three pain killers (ibuprofen, naproxen and diclofenac), 
four antibiotics (erythromycin, roxithromycin, sulfamethoxazole 
and trimethoprim), three psychoactive drugs (fluoxetine, carbama-
zepine and diazepam), three musk fragrances (galaxolide, tonalide 
and celestolide), three estrogens (estrone, 17β-estradiol and 17α
-ethinylestradiol) and four endocrine disruptor compounds - EDCs 
(4-octylphenol, 4-nonylphenol, bisphenol A and triclosan). 
Compound abbreviations are reported in the caption of Fig. 1.
For their determination, 250 mL influent and effluent samples 
were prefiltered (0.70 μm, Millipore) and pre-concentrated by solid 
phase extraction (SPE) prior to analysis with Gas Chromatography 
Mass Spectrometry - GC/MS (pain killers, musk fragrances and 
EDCs) and Liquid Chromatography Tandem Mass Spectrometry 
- LC/MS/MS (antibiotics, estrogens and psychoactive drugs). Further 
details on the limits of detection, quantification and recoveries 
of analytical methods are described in [9] and [10].
It is worth noting that, as we spiked samples by adding three 
estrogens in concentration of 1 μg/L (100 – 1,000 times the usual 
concentration in wastewater), thus E1, E2 and EE2 were by far the 
major estrogenic active substances, due to a relative estrogenic po-
tency 100 – 1,000 times higher than the other spiked EDCs [12].
2.3. Effect-Based Assays
The same SPE as for chemical analyses was executed, and extracts 
dried under nitrogen flow and resuspended in 1 mL dimethyl 
sulfoxide (DMSO), leading thus to an initial enrichment factor 
of 250 mLwastewater/mLextract.
2.3.1. Estrogenic activity
Human breast cancer cell line MCF-7 was selected to measure 
the estrogenic activity. MCF-7 stably transfected with the 
ERE-tK-LUC construct (kindly supplied by Mikko Unkila, Hormos 
Medical Ltd, Turku, Finland) was maintained in DMEM (Modified 
Dulbecco’s Medium, Milan, Italy), supplemented with 10% fetal 
bovine serum, at 37°C and 5% CO2. Cells were plated at a density 
of 2.5∙105 cells/cm2 in several plates containing 1 mL of culture 
medium (phenol red-free DMEM and 5% charcoal-stripped serum). 
24 h later, 1 μL of each DMSO extract (therefore, with a dilution 
factor of 1,000) was added by triplicate and dishes were kept at 
37°C for 24 h. As controls without extracts, one cell-plate was 
supplemented with DMSO solvent, another with ethanol and a 
last one only with cells. After incubation, cells were harvested 
and lysed in passive lysis buffer (Promega, Italy). Lysate was spun 
for 15 s at 12,000 g and supernatant submitted to luciferase activity 
quantification (Luciferase Assay System, Promega, Italy), by means 
of a luminometer (GloMAx, Promega, Italy) over 10 s, and expressed 
as RLU (relative light units) normalized towards protein content 
(Bradford assay, Biorad, Italy). The latter value was then expressed 
as estradiol equivalent concentration (ng-EEQ/Lbioassay), based on 
the calibration curve, and ultimately as ng-EEQ/Lsample using the 
relative enrichment factor (REF). REF represents the combination 
of the initial enrichment factor and the dilution factor in the bioassay 
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plates, as explained by [13]: therefore, REF was equal to 0.25 
mLwastewater/mLbioassay.
For the calibration curve, reference estrogen (E2 dissolved in 
ethanol) was employed, at concentrations corresponding to physio-
logical/sub-physiological doses, i.e. from 10-15 to 10-8 M. The result-
ing curve (sigmoïdal function) was fitted using Graphpad Prism 
6.0 software (GraphPad Software, Inc., USA). Details of cell response 
to the reference estrogen, together with the calibration curve, are 
reported in Fig. S1 and Table S2 of Supplementary Materials.
2.3.2. Mutagenic activity
Mutagenicity was assessed using Ames test, which is able to evidence 
point mutations in bacteria; specifically, we used the TA98 strain 
of Salmonella typhimurium (able to detect frameshift mutagens) 
according to [14]. Bacteria were exposed to increasing doses of 
DMSO extracts: 1-, 5-, 10-, 25- and 50-mL of wastewater equivalents 
per plate. Positive (10 μg/plate of 2-nitrofluorene) and negative 
(DMSO solvent) controls were executed.
Data were expressed as mutagenicity ratio (MR), dividing the 
revertants/plate by the spontaneous mutation rate derived from 
the negative control. Results were considered positive if MR was 
higher than 2 (a response at least twice the negative control).
3. Results and Discussion
As aforementioned, we spiked target OMPs: therefore, raw values 
obtained from bioassays were not discussed themselves, but rather 
used to calculate and compare removal efficiencies, as hereinafter 
discussed. Raw data are however reported in Supplementary 
Materials (Figure S2 for estrogenic and Table S3 for mutagenic 
activity).
Bioassays were the main focus of this paper, while two previous 
papers ([9] and [10] that act as accompanying papers) were entirely 
devoted to the chemical analysis results, specifically explaining 
the behaviour of OMPs in the three studied post-treatment systems 
and their different removal mechanisms.
3.1. Biofiltration Systems
First of all, we analyzed chemical data as background information, 
to see what we should expect from the effect-based assays. Fig. 1 
summarizes the removal efficiencies obtained for targeted OMPs: 
for a quicker understanding, removals were grouped into four catego-
ries with appropriate color coding.
It is clear how GAC biofilter exhibited a great potential for OMPs 
removal: indeed, only the green category (high removal) is repre-
sented in Fig. 1, with efficiencies always above 90% for all targeted 
micropollutants. On the contrary, all the 4 categories are displayed 
in the case of sand biofilter, where OMPs elimination was strongly 
related to their biodegradability: for instance, unsatisfactory abate-
ment characterized the most recalcitrant/hardy biodegradable com-
pounds (such as diclofenac, carbamazepine and diazepam); the 
same compounds, instead, were strongly removed in GAC thanks 
to the adsorption on activated carbon. Further details of the removal 
mechanisms in [9].
Fig. 1. Average OMPs removal efficiencies in biofilters and UV. Compounds are listed according to their behavior in sand biofilter and labelled
as follows: 4-octylphenol (OP), 4-nonylphenol (NP), tonalide (AHTN), galaxolide (HHCB), triclosan (TCS), estrone (E1), ibuprofen (IBP),
17β-estradiol (E2), celestolide (ADBI), erythromycin (ERY), bisphenol A (BPA), roxithromycin (ROX), naproxen (NPX), 17α-ethinylestradiol
(EE2), fluoxetine (FLX), sulfamethoxazole (SMX), trimethoprim (TMP), diclofenac (DCF), carbamazepine (CBZ), diazepam (DZP). The colors
indicate the level of abatement: green = high (> 75%); yellow = mild (50% to 75%); orange = low (25% to 50%); red = absent (< 
25%) (for interpretation of the references to color in this figure legend, the reader is referred to the web version of this article).
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Fig. 2. Estrogenic bioassay VS chemical analysis. Average removal of 
estrogenic activity in biofilters and UV (bioassay response), and 
comparison with chemical analysis (i.e., estrogens removal). The 
colors indicate the level of abatement: green = high (> 75%); 
yellow = mild (50% to 75%); orange = low (25% to 50%); 
red = absent (< 25%) (for interpretation of the references to 
color in this figure legend, the reader is referred to the web 
version of this article).
Then, we examined the bioassays outcomes for the effect-based 
analysis. Fig. 2 reports the removal of estrogenic activity, calculated 
on the basis of estradiol equivalent concentrations (ng-EEQ/L, reported 
in Fig. S2 of Supplementary Materials). Both GAC and sand biofilters 
reached a strong abatement of estrogenicity (higher than 90%), in 
agreement with the outcomes of other researches ([15] among others).
To link the removal of the most critical pollutants exhibiting estro-
genic activity (i.e., the 3 estrogens) with the reduced estrogenicity, 
we plotted in Fig. 2 both the information (chemical and biological), 
and we recorded the accordance of their outcome: indeed, estro-
genicity abatement (> 90%) was strongly in agreement with estro-
gens removal, that also topped 90% (except EE2 in sand biofiltration, 
however removed at a 70% extent). This outcome is a confirmation 
that no estrogenically active by-products were formed during bio-
filtration, as already postulated by other authors [16]: by using 
an approach only based on chemical analysis, it would not have 
been possible to get such a holistic answer, as biotransformation 
products would not have been taken into account.
On the other hand, mutagenic activity was not observed, neither 
in the influent nor in the effluent of the biofilters, since the muta-
genicity ratio was always below the threshold of 2 (Fig. 3, while 
the raw values of revertants/plate are reported in Table S3 of 
Supplementary Materials). This is explained by the fact that spiked 
OMPs are not recognized as mutagenic compounds, and GAC and 
sand biofiltration do not generate transformation products able 
to induce frameshift mutations [16].
Notwithstanding, the lack of transformation products after bio-
filters is not tout court, but only related to those compounds respon-
sible for monitored biological activities (estrogenicity and muta-
genicity): indeed, the formation of transformation products in/dur-
ing biofiltration is evident elsewhere [17] for other OMPs.
Fig. 3. Average Mutagenicity Ratio obtained using Ames test, for GAC 
and sand biofilters (n.a. = not available). Background color in-
dicates a negative (green = MR < 2) or positive (red = MR 
> 2) answer (for interpretation of the references to color in 
this figure legend, the reader is referred to the web version 
of this article).
3.2. UV Systems
UV irradiation showed, as also sand biofiltration did, a variety 
in OMPs behavior, with 3 categories on the ground: some compounds 
(e.g. diclofenac and estrogens) were remarkably eliminated (green 
category of Fig. 1), while others (erythromycin, carbamazepine 
and diazepam) fell in the orange category (i.e. low abatement). 
As extensively reported in [10], the reason lies in the different 
photosensitivity of target OMPs, whose removal efficiencies are 
very closely related to.
Moreover, it is well known [18] that UV treatment is not able 
to reach the complete mineralization of pollutants, but only to 
reduce their complexity owing to the rupture of bonds by UV 
light action. The transformation of parent compounds into by-prod-
ucts was clearly evidenced by the effect-based estrogenicity assay. 
Indeed, when we again linked the removal of the most critical 
pollutants exhibiting estrogenic activity (i.e., the 3 estrogens) with 
the reduced estrogenicity (Fig. 2), we recorded divergent outcomes: 
after the UV irradiation the real estrogenic burden measured with 
the bioassay remained almost unchanged in the effluent (only a 
10% removal efficiency), despite the satisfactory abatement of the 
estrogens (> 80%). As anticipated before, we can therefore attribute 
this outcome to the formation of transformation products that still 
possess estrogenic activity, but not detected by the target chemical 
analysis: for instance, the hydroxylation of estradiol into 2-hydrox-
yestradiol, which is able to form hydrogen bonds with the estrogen 
receptor, was observed by [18] after UV. This behavior, therefore, 
could explain the persistence of the estrogenic activity after UV 
treatment, as also observed in other works ([19] among others). 
On the contrary, it is highly unlikely that the low estrogenicity 
removal could be attributable to the low elimination rate of the 
UV technique recorded for other micropollutants (CBZ, DZP, etc).
As mutagenicity is concerned, UV system exhibited again some 
weaknesses (Fig. 4). While the determination of the mutagenicity 
was not possible in the influent at the highest tested doses (25- 
and 50-mL wastewater equivalent/plate), because of the strong toxic 
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Fig. 4. Mutagenicity ratio obtained using Ames test, for UV treatment 
(tox = toxic to bacteria). Background color indicates a negative 
(green = MR < 2) or positive (red = MR > 2) answer (for 
interpretation of the references to color in this figure legend, 
the reader is referred to the web version of this article).
effect on bacteria, the effluent maintained a borderline mutagenicity 
strength, with MR values slightly above the threshold of 2. Similar 
findings were also achieved by other authors [20], that have shown 
how UV irradiation could lead to the formation of potential muta-
genic by-products.
4. Conclusions
This study represents the last piece of a bigger “puzzle”, preceded 
by the works [9] and [10] that analysed the behaviour of several 
organic micropollutants in three post-treatment technologies for sec-
ondary effluents polishing. In this last work, their efficiency was 
evaluated towards two specific modes of toxic actions (the most 
commonly studied in wastewater: estrogenic and mutagenic activity), 
with an integrated chemical-biological approach, i.e. by coupling 
the information derived from OMPs detection with those derived 
from the effect-based approach (estrogenic and mutagenic activity).
The results indicated that bioassays are needed to correctly 
gauge the ecohazard posed by micropollutants, as there was no 
direct link between OMPs removal and toxicity attenuation. In 
the case of estrogenicity, indeed, although both biofiltration and 
UV treatment satisfactory eliminated the estrogens (E1, E2, EE2), 
only the former was able to make the estrogenic load plummet, 
while UV treatment left it almost unchanged. Moreover, unlike 
biofilters, after UV treatment also a slight mutagenic effect was 
recorded. Therefore, effect-based assays suggested how photolysis 
could generate by-products, missed by the target chemical analysis 
but still bioactive and therefore detected by bioassays.
In conclusion, the application of a multitiered bio-chemical strat-
egy may allow to properly profile tertiary treatments, and eventually 
leading to the optimization of their operational conditions in order 
to obtain a removal not only of OMPs, but also of their toxicity.
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